Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
88.39 +4.95 / +5.93%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
88.45 +0.06 / +0.07%
Volume: 830.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Operating ActivitiesNet Income / Starting Line508.1M74.5M-51.5M48.2M
Total Other Cash Flow245.5M156.4M176.0M246.6M
Funds From Operations1.1B700.4M714.3M824.0M
Funds From/For Other Operating Expenses374.3M209.3M299.6M165.5M
Net Cash Flow - Operating Activities749.1M491.1M414.6M658.4M
InvestingIncrease In Investments-67.8M0.000.000.00
Decrease In Investments125.6M17.7M159.1M-1.1M
Capital Expenditures-79.9M-65.8M-47.3M-43.2M
Fixed Asset Disposal-32.1M------
Net Assets From Acquisitions -88.8M-795.0M-13.2B581.8M
Other Investing - Uses0.00-10.3B10.3B258.3K
Other Investing - Sources--500.0K----
Net Cash Flow Investing-203.0M-11.2B-2.7B540.5M
FinancingShort Term Borrowings-2.3M0.000.000.00
Long Term Borrowings630.5M12.0B4.9B-738.5M
Long Term Debt Reduction-1.7B-1.1B-3.4B194.9M
Net Proceeds Stock Sale6.3M1.4B14.3M-65.6M
Common Preferred Redeemed0.000.00-50.2M2.5M
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing-511.2K18.8M6.9M-5.0M
Other Uses - Financing10.4M28.2M115.4M168.8M
Net Cash Flow - Financing-1.0B12.3B1.4B-780.6M
Exchange RateEffect of Exchange Rate on Cash-13.3M-15.1M2.9M-8.8M
Net Change In Cash-465.8M1.6B-906.4M418.4M